Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, Machine Learning in Bioinformatics, Epigenetics and DNA Methylation, and Cancer Immunotherapy and Biomarkers.
Abstract LB-C009: Tumor methylation subtypes predict the clinical outcome to immunotherapy in pleural mesothelioma patients from the NIBIT-EPI-MESO study
Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy
Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression
Abstract 4841: DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches
Abstract LB241: FateAI: Analysis of circulating DNA fragmentomics with an artificial intelligence model for cancer screening
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy
Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial
Loss of circadian rhythmicity in bdnf knockout zebrafish larvae